Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
09/01/2011 | CA2788440A1 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
08/31/2011 | EP2362226A1 Diagnostic method for neurodegenerative diseases based on measurement of SIRT1 levels or activity |
08/31/2011 | EP2361914A1 [(1h-indol-5-yl)-heteroaryloxy]-(1-aza-bicyclo[3.3.1]nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders. |
08/31/2011 | EP2361908A1 Pyrimidine compounds useful for the treatment of CNS diseases |
08/31/2011 | EP2361904A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride and crystalline forms thereof |
08/31/2011 | EP2361638A1 A beta 1-42 specific monoclonal antibodies with therapeutic properties |
08/31/2011 | EP2361631A1 Treatment of alpha-galactosidase a deficiency |
08/31/2011 | EP2361629A1 Prevention and treatment of synucleinopathic disease |
08/31/2011 | EP2361513A1 DHA- and EPA-rich nutritional ingredient |
08/31/2011 | EP2361247A2 Flupirtine hydrochloride maleic acid cocrystal |
08/31/2011 | EP2361246A1 Oxopiperidinyl and pyranyl sulfonamides as ampa potentiators |
08/31/2011 | EP2361089A1 Compositions and methods for the treatment of altered -synuclein function |
08/31/2011 | EP2361088A2 Method of inducing cleavage of amyloid precursor protein to form a novel fragment |
08/31/2011 | EP2361081A1 Multi portion intra-oral dosage form and use thereof |
08/31/2011 | EP2271638B1 Modulators of dopamine neurotransmission |
08/31/2011 | EP2257553B1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
08/31/2011 | EP2257545B1 Pyrrolidinyl derivatives and uses thereof |
08/31/2011 | EP2231655B1 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl)benzenesulfonamide derivatives and related compounds as modulators of ion channels for the treatment of pain |
08/31/2011 | EP2205594B1 1,3,5-trisubstituted triazole derivative |
08/31/2011 | EP2203426B1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
08/31/2011 | EP2187915B1 Use of the peptide phpfhlfvy (renin inhibitor) in anti-angiogenic therapy of certain diseases |
08/31/2011 | EP2183027B1 Organic compounds |
08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
08/31/2011 | EP1781291B9 Opioids for the treatment of the restlessness of the lower limbs |
08/31/2011 | EP1401498B1 Anti-ngf antibodies for the treatment of various disorders |
08/31/2011 | EP1095140B1 Neurotrophic factors |
08/31/2011 | CN1990478B 6-aryl-3-substituted methylene pyranone compounds, preparation process and use thereof |
08/31/2011 | CN1946726B Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
08/31/2011 | CN1939920B Eastern poppy base compound and its medical use |
08/31/2011 | CN1861604B Crystal form of asenapine maleate |
08/31/2011 | CN102171249A Long-acting interferons and derivatives thereof and methods thereof |
08/31/2011 | CN102171221A Novel fused aminodihydrothiazine derivative |
08/31/2011 | CN102171219A Crystalline forms of a pyridine derivative |
08/31/2011 | CN102171208A Isatin derivatives for use as in vivo imaging agents |
08/31/2011 | CN102171205A Pyrazinone modulator of corticotropin-releasing factor receptor activity |
08/31/2011 | CN102171196A Oxazole derivatives useful as inhibitors of FAAH |
08/31/2011 | CN102171189A Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
08/31/2011 | CN102170884A Oral formulation |
08/31/2011 | CN102170874A Compositions and methods for treating psychiatric disorders |
08/31/2011 | CN102170872A Method of modulating membrane potential of a cell |
08/31/2011 | CN102170870A An extended release pharmaceutical composition of entacapone or salts thereof |
08/31/2011 | CN102170869A Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
08/31/2011 | CN102167730A Conotoxin analog Glu-Con-G[1-13], and design and synthesis method and application thereof |
08/31/2011 | CN102167729A Conotoxin analog Glu-Con-G (Glutamate-Conantokin-G) with morphine-dependent resistance and analgesic effect |
08/31/2011 | CN102167695A Benzimidazole-carbonyl-pyridine-amino-ehtyl-propionate hemihyrate and its use |
08/31/2011 | CN102166359A Carbostyril derivatives and mood stabilizers for treating mood disorders |
08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
08/31/2011 | CN102166341A Preparation method of ease powder antidepressant extractive |
08/31/2011 | CN102166319A Soup for treating wind cold |
08/31/2011 | CN102166287A Recovery mud moxibustion and preparation method |
08/31/2011 | CN102166271A Anti-alcohol and liver-protection Chinese medicinal composition and preparation method thereof |
08/31/2011 | CN102166254A Oil-in-water type spearmint oil nano emulsion and method for preparing same |
08/31/2011 | CN102166246A Oil-in-water type atractylis oil nano emulsion oral liquid |
08/31/2011 | CN102166242A Asarum oil nano emulsion and method for preparing same |
08/31/2011 | CN102166234A Oil-in-water type nanoemulsion oral liquid with bupleurum oil and preparation method thereof |
08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
08/31/2011 | CN102166200A Freeze-drying composition containing cerebroprotein hydrolysates and preparation method of freeze-drying composition |
08/31/2011 | CN102166188A Oil-in-water type nanoemulsion preparation of camphor oil and preparation method thereof |
08/31/2011 | CN102166185A Isotonic naloxone injection and preparation method thereof |
08/31/2011 | CN101912564B Traditional Chinese medicine for treating chronic gastritis |
08/31/2011 | CN101850097B Chinese medicinal composition for treating medial headache and migraine and preparation method thereof |
08/31/2011 | CN101816768B Chinese medicinal composition for treating somatoform disorder and preparation method thereof |
08/31/2011 | CN101810815B Antismoking liqueur |
08/31/2011 | CN101810808B Chinese medicinal composition for treating tremor and preparation method thereof |
08/31/2011 | CN101735239B Preparation method of anhydrous olanzapine crystal form II |
08/31/2011 | CN101721539B Traditional Chinese medicine sachet and preparation method thereof |
08/31/2011 | CN101716322B Traditional Chinese medicine composition for treating heart-blood deficiency disease and preparation method thereof |
08/31/2011 | CN101716303B Traditional Chinese medicine composition for treating heart-deficiency timidity disease and preparation method thereof |
08/31/2011 | CN101711781B Method for extracting and purifying flavonoids compounds by ion-exchange fibers |
08/31/2011 | CN101703681B Chinese medicinal granules for treating cardiovascular neurosis and preparation method thereof |
08/31/2011 | CN101695504B Preparation method of nanometer pearl powder |
08/31/2011 | CN101637572B Traditional Chinese medicine tablet for improving sleep |
08/31/2011 | CN101612160B Application of 20(S)-ginsenoside Rh2 compound in preparing antidepressant medicament |
08/31/2011 | CN101612159B Application of 20(S)-ginsenoside Rh2 compound in preparing anti-fatigue medicament |
08/31/2011 | CN101607037B Detecting method of lanzhi brain-tranquilizing capsule |
08/31/2011 | CN101579511B Drug combination used for treating schizophrenia |
08/31/2011 | CN101579387B Medicinal composition for treating anorexia nervosa and preparation method thereof |
08/31/2011 | CN101579377B Medicinal composition for treating senile dementia |
08/31/2011 | CN101481395B Preparation of lactitol |
08/31/2011 | CN101480471B Medicament for treating parkinson's disease and preparation method thereof |
08/31/2011 | CN101422517B Traditional Chinese medicine composition capable of fighting against senium and reinforcing memory and preparation method thereof |
08/31/2011 | CN101384588B Process for preparing intermediates to 5-ht4 receptor agonist compounds |
08/31/2011 | CN101370807B Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via GABA receptors |
08/31/2011 | CN101360709B Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
08/31/2011 | CN101322706B Applications of hexa-gelsemicine in preparing medicament for treating chronic ache |
08/31/2011 | CN101322705B Applications of koumine in preparing medicament for treating chronic ache |
08/31/2011 | CN101316818B 3-amino-1-arylpropyl indoles and aza-substituted indoles |
08/31/2011 | CN101293054B Chinese Medicinal composition for treating kidney Qi deficiency |
08/31/2011 | CN101112201B Natural perfume satchel for expelling worm and disinfecting |
08/30/2011 | US8008488 Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligands |
08/30/2011 | US8008440 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
08/30/2011 | US8008435 Polymer stabilized neuropeptides |
08/30/2011 | US8008353 Alzheimer's disease; small molecule amine salts |
08/30/2011 | US8008341 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
08/30/2011 | US8008323 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
08/30/2011 | US8008299 Urotensin II receptor antagonists |
08/30/2011 | US8008295 Tyrosine kinase inhibitors |
08/30/2011 | US8008270 Antiviral oligonucleotides targeting viral families |
08/30/2011 | US8008269 Antiviral oligonucleotides |
08/30/2011 | US8007830 Oral granules of montelukast sodium; e.g. spray-dried mannitol coated with said drug; may be ingested directly or mixed with food or other comestibles for patients who have difficulty swallowing |